We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

582 hedge funds and large institutions have $4.92B invested in iShares US Medical Devices ETF in 2020 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 242 increasing their positions, 142 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

537% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 19

70% more repeat investments, than reductions

Existing positions increased: 242 | Existing positions reduced: 142

19% more funds holding in top 10

Funds holding in top 10: 2631 (+5)

19% more funds holding

Funds holding: 489582 (+93)

14% more capital invested

Capital invested by funds: $4.31B → $4.92B (+$601M)

3% more ownership

Funds ownership: 316.37%319.37% (+3%)

87% less call options, than puts

Call options by funds: $15.7M | Put options by funds: $124M

Holders
582
Holders Change
+93
Holders Change %
+19.02%
% of All Funds
10.3%
Holding in Top 10
31
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+19.23%
% of All Funds
0.55%
New
121
Increased
242
Reduced
142
Closed
19
Calls
$15.7M
Puts
$124M
Net Calls
-$108M
Net Calls Change
-$35.9M
Name Holding Trade Value Shares
Change
Change in
Stake
SPFA
326
Summit Place Financial Advisors
New Jersey
$769K -$205K -3,930 -22%
FTUS
327
Flow Traders U.S.
New York
$759K -$140K -2,676 -16%
WWM
328
Western Wealth Management
Colorado
$743K -$179K -3,432 -20%
BCM
329
Breiter Capital Management
Florida
$707K
NP
330
NorthRock Partners
Minnesota
$695K -$23.2K -444 -3%
GLA
331
Good Life Advisors
Pennsylvania
$691K -$2.19K -42 -0.3%
CPC
332
Cookson Peirce & Co
Pennsylvania
$690K -$23.8K -456 -3%
SA
333
Strategic Advisors
New York
$688K
Rockefeller Capital Management
334
Rockefeller Capital Management
New York
$681K +$101K +1,926 +18%
MSFS
335
Main Street Financial Solutions
Pennsylvania
$680K +$651K +12,462 New
WIA
336
World Investment Advisors
California
$679K +$335K +6,402 +123%
CAPTRUST Financial Advisors
337
CAPTRUST Financial Advisors
North Carolina
$675K +$32.6K +624 +5%
GRP
338
Global Retirement Partners
California
$674K +$24.5K +468 +4%
FWSM
339
First Wilshire Securities Management
California
$671K
PCG
340
Private Capital Group
Connecticut
$670K +$88.4K +1,692 +16%
PFGIA
341
Patriot Financial Group Insurance Agency
Massachusetts
$663K -$16K -306 -2%
PWW
342
Pettyjohn Wood & White
Virginia
$660K -$62.7K -1,200 -9%
CFA
343
Carroll Financial Associates
North Carolina
$658K +$60.2K +1,152 +11%
MWM
344
Meridian Wealth Management
Kentucky
$640K +$614K +11,742 New
SWM
345
SigFig Wealth Management
California
$631K +$151K +2,886 +33%
KWM
346
Keebeck Wealth Management
Illinois
$624K +$598K +11,436 New
GDP
347
Great Diamond Partners
Maine
$617K +$73.7K +1,410 +14%
CFA
348
Cahill Financial Advisors
Minnesota
$606K +$46.7K +894 +9%
VWA
349
V Wealth Advisors
Kansas
$600K +$240K +4,584 +71%
AWE
350
Avidian Wealth Enterprises
Texas
$594K -$8.78K -168 -2%

IHI Hedge Fund Activity: Q4 2020 in Review

582 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2020, worth a combined $4.92B — up 14% from $4.31B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new IHI positions and 19 closed out — a net gain of 102 holders — while 242 added to existing stakes and 142 trimmed.

The largest buyer was AssetMark Inc, adding an estimated $57.8M. The largest seller was JP Morgan Chase, cutting an estimated $123M.

  • 582 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2020, up from 489 in Q3 2020.
  • Funds reported $4.92B of iShares US Medical Devices ETF stock for Q4 2020, up 14% quarter-over-quarter.
  • 121 funds opened new iShares US Medical Devices ETF positions in Q4 2020 and 19 closed out, a net change of +102 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2020 was AssetMark Inc, an estimated $57.8M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2020 was JP Morgan Chase, an estimated $123M sold.

Based on aggregated 13F filings for Q4 2020.